Xu YY - Search Results

1

Liposome-Encapsulated Zoledronate Favors Tumor Vascular Normalization and Enhances Anticancer Efficacy of Cisplatin.

Cai XJ, Fei WD, Xu YY, Xu H, Yang GY, Cao JW, Ni JJ, Tao K, Wang Z. Cai XJ, et al. Among authors: xu yy, xu h. AAPS PharmSciTech. 2020 Jan 7;21(2):57. doi: 10.1208/s12249-019-1614-6. AAPS PharmSciTech. 2020. PMID: 31912318

2

Nanomaterials in controlled drug release.

Cai XJ, Xu YY. Cai XJ, et al. Among authors: xu yy. Cytotechnology. 2011 Aug;63(4):319-23. doi: 10.1007/s10616-011-9366-5. Epub 2011 Jul 1. Cytotechnology. 2011. PMID: 21720796 Free PMC article.

3

Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer.

Cai XJ, Wang Z, Cao JW, Ni JJ, Xu YY, Yao J, Xu H, Liu F, Yang GY. Cai XJ, et al. Among authors: xu yy, xu h. Oncotarget. 2017 Aug 24;8(48):84248-84257. doi: 10.18632/oncotarget.20539. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137420 Free PMC article.

4

Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.

Cai XJ, Fei WD, Xu YY, Xu H, Yang GY, Cao JW, Ni JJ, Wang Z. Cai XJ, et al. Among authors: xu yy, xu h. Drug Deliv Transl Res. 2020 Feb;10(1):93-107. doi: 10.1007/s13346-019-00665-8. Drug Deliv Transl Res. 2020. PMID: 31418132

5

Candesartan treatment enhances liposome penetration and anti-tumor effect via depletion of tumor stroma and normalization of tumor vessel.

Cai XJ, Wang Z, Xu YY, Yang GY, Zhang RY, Wang Y. Cai XJ, et al. Among authors: xu yy. Drug Deliv Transl Res. 2021 Jun;11(3):1186-1197. doi: 10.1007/s13346-020-00842-0. Drug Deliv Transl Res. 2021. PMID: 32822012

6

Correction to: Candesartan treatment enhances liposome penetration and anti-tumor effect via depletion of tumor stroma and normalization of tumor vessel.

Cai XJ, Wang Z, Xu YY, Yang GY, Zhang RY, Wang Y. Cai XJ, et al. Among authors: xu yy. Drug Deliv Transl Res. 2021 Jun;11(3):1198. doi: 10.1007/s13346-020-00844-y. Drug Deliv Transl Res. 2021. PMID: 32851595 No abstract available.

7

Safety, efficacy, and serum concentration monitoring of bedaquiline in Chinese patients with multidrug-resistant tuberculosis.

Li J, Yang G, Cai Q, Wang Y, Xu Y, Zhang R, Lang Y, Cai X. Li J, et al. Int J Infect Dis. 2021 Sep;110:179-186. doi: 10.1016/j.ijid.2021.07.038. Epub 2021 Jul 19. Int J Infect Dis. 2021. PMID: 34293490 Free article.

8

Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report.

Zhang RY, Zhang JJ, Li JM, Xu YY, Xu YH, Cai XJ. Zhang RY, et al. Among authors: xu yh, xu yy. World J Clin Cases. 2022 Aug 6;10(22):7906-7912. doi: 10.12998/wjcc.v10.i22.7906. World J Clin Cases. 2022. PMID: 36158491 Free PMC article.

9

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis.

Yuan Y, Li J, Chen Y, Cai Q, Xu Y, Lin L, Lang Y, Guo S, Zhang R, Cai X. Yuan Y, et al. Front Pharmacol. 2022 Sep 9;13:946058. doi: 10.3389/fphar.2022.946058. eCollection 2022. Front Pharmacol. 2022. PMID: 36160387 Free PMC article.

10

Modulating tumour vascular normalisation using triptolide-loaded NGR-functionalized liposomes for enhanced cancer radiotherapy.

Xu YY, Chen YH, Jin J, Yuan Y, Li JM, Cai XJ, Zhang RY. Xu YY, et al. J Liposome Res. 2023 Sep;33(3):251-257. doi: 10.1080/08982104.2022.2161095. Epub 2023 Jan 4. J Liposome Res. 2023. PMID: 36601687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,091 results

Search Page

Filters